Literature DB >> 26190329

A case of autoimmune pancreatitis with metachronous appearance of idiopathic thrombocytopenic purpura.

Hiroaki Sawai1, Hiroyuki Matsubayashi2, Masaki Tanaka2, Yuichiro Yamaguchi2, Hiroyuki Ono2.   

Abstract

Autoimmune pancreatitis (AIP) is often associated with systemic disorders, but a case accompanied with idiopathic thrombocytopenic purpura (ITP) is very rare. A 67-year-old man was referred to our institution with complaints of abdominal pain and jaundice. Multiple images showed diffuse enlargement of the pancreas, narrowing of the main pancreatic duct, stenosis of the lower common bile duct and thickness of the anterior wall of the abdominal aorta. Serum levels of IgG and IgG4 were elevated and a diagnosis of AIP was made based on the Japanese criteria. The pancreatic lesion and serum markers responded well to steroid therapy. A year after withdrawal of steroids, the peripheral blood platelet levels gradually decreased to 5.8 × 10(4)/μl. With elevated serum PAIgG levels and exclusion of other causes, we diagnosed ITP. Immediately after restarting steroid therapy, the platelet level in the peripheral blood recovered.

Entities:  

Keywords:  Autoimmune pancreatitis; Idiopathic thrombocytopenic purpura; IgG4; Retroperitoneal fibrosis; Steroid

Year:  2010        PMID: 26190329     DOI: 10.1007/s12328-010-0166-9

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  14 in total

Review 1.  [Epidemiology and long-term prognosis of ITP].

Authors:  Mitsuhiro Omine
Journal:  Nihon Rinsho       Date:  2003-04

2.  A case of autoimmune pancreatitis complicated with immune thrombocytopenia during maintenance therapy with prednisolone.

Authors:  Akihiro Nakamura; Hitoshi Funatomi; Atsushi Katagiri; Kouzou Katayose; Katsuya Kitamura; Tetsuya Seki; Fuyuhiko Yamamura; Yuuji Aoyagi; Hitoshi Nishida; Keiji Mitamura
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.199

3.  Improvement of thrombocytopenia in a patient with autoimmune pancreatitis after Helicobacter pylori eradication.

Authors:  Hiroyuki Miyatani; Yukio Yoshida; Masatoshi Ikeda; Noriyoshi Sagihara
Journal:  Intern Med       Date:  2008-02-15       Impact factor: 1.271

4.  Successful treatment of autoimmune pancreatitis complicated with autoimmune thrombocytopenia and interstitial pneumonia by prednisolone.

Authors:  Kazuyuki Murase; Takuya Matsunaga; Tsuyoshi Hayashi; Hirotoshi Ishiwatari; Naoko Araki; Satoshi Iyama; Tsutomu Sato; Masayoshi Kobune; Rishu Takimoto; Koji Miyanishi; Toru Miyazaki; Hisami Ikeda; Junji Kato; Yoshiro Niitsu
Journal:  Intern Med       Date:  2008-06-02       Impact factor: 1.271

5.  Sensitivity and specificity of CT in the diagnosis of inflammatory abdominal aortic aneurysms.

Authors:  Misako Iino; Sachio Kuribayashi; Satoshi Imakita; Makoto Takamiya; Hiroshi Matsuo; Yutaka Ookita; Motomi Ando; Hatsue Ueda
Journal:  J Comput Assist Tomogr       Date:  2002 Nov-Dec       Impact factor: 1.826

6.  [A case of autoimmune pancreatitis complicated with immune thrombocytopenia].

Authors:  Hirofumi Fukushima; Emiko Katou; Kouji Nagayama; Akira Shirachi; Michio Sata
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  2006-06

7.  Inflammatory abdominal aortic aneurysm.

Authors:  David B Hellmann; David J Grand; Julie A Freischlag
Journal:  JAMA       Date:  2007-01-24       Impact factor: 56.272

Review 8.  Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis.

Authors:  K Yoshida; F Toki; T Takeuchi; S Watanabe; K Shiratori; N Hayashi
Journal:  Dig Dis Sci       Date:  1995-07       Impact factor: 3.199

9.  Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis.

Authors:  Hideaki Hamano; Norikazu Arakura; Takashi Muraki; Yayoi Ozaki; Kendo Kiyosawa; Shigeyuki Kawa
Journal:  J Gastroenterol       Date:  2007-02-06       Impact factor: 7.527

10.  Chronic periaortitis.

Authors:  R N Jois; K Gaffney; T Marshall; D G I Scott
Journal:  Rheumatology (Oxford)       Date:  2004-07-20       Impact factor: 7.580

View more
  7 in total

Review 1.  Diagnosis of autoimmune pancreatitis.

Authors:  Hiroyuki Matsubayashi; Naomi Kakushima; Kohei Takizawa; Masaki Tanaka; Kenichiro Imai; Kinichi Hotta; Hiroyuki Ono
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

2.  Reduction of splenic volume by steroid therapy in cases with autoimmune pancreatitis.

Authors:  Hiroyuki Matsubayashi; Katsuhiko Uesaka; Hideyuki Kanemoto; Takeshi Aramaki; Yoshihiro Nakaya; Naomi Kakushima; Hiroyuki Ono
Journal:  J Gastroenterol       Date:  2012-10-18       Impact factor: 7.527

3.  IgG4-Related Pancreatitis and Immune Thrombocytopenia: A Case Report and Literature Review.

Authors:  Claire Sakiyama; Stephen Sullivan
Journal:  Cureus       Date:  2017-09-28

4.  Concurrent Autoimmune Neutropenia and Idiopathic Thrombocytopenic Purpura Associated with IgG4-related Diease.

Authors:  Yayoi Shimazu; Tatsuki Uchiyama; Chisaki Mizumoto; Tomoharu Takeoka; Masaaki Tsuji; Kenjiro Tomo; Koji Takaori; Naoki Sakai; Tomoko Okuno; Tatsuharu Ohno
Journal:  Intern Med       Date:  2018-02-28       Impact factor: 1.271

5.  Immune thrombocytopenic purpura increased risk of subsequent pancreatitis: A Nationwide population cohort study.

Authors:  Shih-Chi Wu; Sheng-Fung Lin; Chu-Wen Fang; I-Ju Tsai; Wen-Chi Yang
Journal:  Sci Rep       Date:  2019-11-15       Impact factor: 4.379

6.  Transpapillary biliary stenting is a risk factor for pancreatic stones in patients with autoimmune pancreatitis.

Authors:  Hiroyuki Matsubayashi; Yoshihiro Kishida; Tomohiro Iwai; Katsuyuki Murai; Masao Yoshida; Kenichiro Imai; Yusuke Yamamoto; Masataka Kikuyama; Hiroyuki Ono
Journal:  Endosc Int Open       Date:  2016-08-08

Review 7.  Steroid Therapy and Steroid Response in Autoimmune Pancreatitis.

Authors:  Hiroyuki Matsubayashi; Hirotoshi Ishiwatari; Kenichiro Imai; Yoshihiro Kishida; Sayo Ito; Kinichi Hotta; Yohei Yabuuchi; Masao Yoshida; Naomi Kakushima; Kohei Takizawa; Noboru Kawata; Hiroyuki Ono
Journal:  Int J Mol Sci       Date:  2019-12-30       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.